Montelukast Prescribing at TOWER HILL PARTNERSHIP
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
2,486
Total Quantity
57.5K
NHS Cost
£2.7K
vs National Avg
+263.1%
TOWER HILL PARTNERSHIP prescribed 2,486 items of Montelukast over the last 12 months at a cost of £2,703 to the NHS. This is 263.1% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
215
Jun 2026
230
Jun 2026
242
Jun 2026
212
Jun 2026
192
Jun 2026
196
Jun 2026
205
Jun 2026
210
Jun 2026
207
Jun 2026
190
Jun 2026
210
Jun 2026
177
Prescribing Details
| Total Items | 2,486 |
|---|---|
| Total Quantity | 57,511 |
| Total NHS Cost | £2,703 |
| Presentations | 4 different forms |
| vs National Average | +263.1% |
Montelukast Prescribing Comparison
| This practice | 2,486 items |
|---|---|
| National average per practice | 685 items |
| Difference | +263.1% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.